These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27580387)

  • 61. Current management of intestinal bowel disease: the role of surgery.
    Solina G; Mandalà S; La Barbera C; Mandalà V
    Updates Surg; 2016 Mar; 68(1):13-23. PubMed ID: 27067590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MR colonography with a fecal tagging technique and water-based enema for the assessment of inflammatory bowel disease.
    Boraschi P; Donati F
    Jpn J Radiol; 2016 Aug; 34(8):585-94. PubMed ID: 27209295
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology.
    Bombardieri E; Carrio I; Gonzalez P; Serafini A; Turner JH; Virgolini I; Maffioli L
    Int J Oncol; 1999 May; 14(5):877-90. PubMed ID: 10200337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Common diagnostic flow charts for diagnosis and management of patients with an inflammatory bowel disease.
    Martin-Comin J; Laghi A; Reinisch W
    Q J Nucl Med Mol Imaging; 2014 Mar; 58(1):20-32. PubMed ID: 24469569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nuclear Medicine, Molecular Imaging, and Theranostics: The Future Is Bright.
    Czernin J; Calais J
    J Nucl Med Technol; 2020 Jun; 48(Suppl 1):82S-83S. PubMed ID: 32605963
    [No Abstract]   [Full Text] [Related]  

  • 70. Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions.
    Panés J
    Acta Physiol Scand; 2001 Sep; 173(1):159-65. PubMed ID: 11678739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.
    Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Ascolani M; Sedda S; Antenucci C; Ruffa A; Caprioli F; MacDonald TT; Pallone F; Monteleone G
    Inflamm Bowel Dis; 2013 Mar; 19(3):501-11. PubMed ID: 23429442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
    Czernin J
    J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
    [No Abstract]   [Full Text] [Related]  

  • 73. SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
    Schwarz SW
    J Nucl Med; 2017 Jun; 58(6):19N. PubMed ID: 28572297
    [No Abstract]   [Full Text] [Related]  

  • 74. SNMMI 2019 Annual Meeting.
    Collingridge D
    Lancet Oncol; 2019 Aug; 20(8):1057. PubMed ID: 31257179
    [No Abstract]   [Full Text] [Related]  

  • 75. Molecular imaging within the lower gastrointestinal tract: From feasibility to future.
    Rath T; Kiesslich R; Neurath MF; Atreya R
    Dig Endosc; 2018 Nov; 30(6):730-738. PubMed ID: 30075487
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nuclear medicine imaging in infection and inflammation.
    Peters AM
    J R Coll Physicians Lond; 1998; 32(6):512-9. PubMed ID: 9881304
    [No Abstract]   [Full Text] [Related]  

  • 77. A Conversation Between Joanna Fowler and Johannes Czernin.
    Fowler JS; Czernin J
    J Nucl Med; 2019 Sep; 60(9):1191-1193. PubMed ID: 31481591
    [No Abstract]   [Full Text] [Related]  

  • 78. Nuclear medicine and anatomic pathology in personalized medicine: a challenging alliance.
    Urbano N; Scimeca M; Bonanno E; Schillaci O
    Per Med; 2018 Nov; 15(6):457-459. PubMed ID: 30398094
    [No Abstract]   [Full Text] [Related]  

  • 79. Has molecular imaging delivered to drug development?
    Murphy PS; Patel N; McCarthy TJ
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038381
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advancing molecular imaging: a chairman's perspective on how radiology can meet the challenge.
    Hricak H
    Pediatr Radiol; 2011 Feb; 41(2):141-3. PubMed ID: 20809095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.